TY - JOUR AU - K, Venugopal AU - P.R, Sreelatha AU - T.P, Thresiamma PY - 2020/06/20 Y2 - 2024/03/28 TI - EFFECT OF AYURVEDIC IMMUNOMODULATOR ON TREATMENT OF TUBERCULOSIS: A CASE CONTROL STUDY JF - International Journal of Research -GRANTHAALAYAH JA - Int. J. Res. Granthaalayah VL - 8 IS - 5 SE - Articles DO - 10.29121/granthaalayah.v8.i5.2020.202 UR - https://www.granthaalayahpublication.org/journals/granthaalayah/article/view/IJRG20_B05_3396 SP - 390-394 AB - <p>Tuberculosis is on increase worldwide. WHO estimates that nearly 1.7 Billions are infected with Mycobacterium Tuberculosis, out of which approximately 20 Millions are active cases. 3 Million die each year and 8 Million new cases occur in each year. [1] India is one of the 22 high burden countries. Here nearly 300 Million people are infected with Mycobacterium tuberculosis [2]. 12 to 14 Million have active disease and there are about 5 lakh deaths per year. [3],[4] The problem in India is on the verge of an explosion with the emergence of increasing HIV infection and spread of Multi drug Resistant TB.</p> ER -